Carroll Financial Associates, Inc. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
Carroll Financial Associates, Inc. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2021$6,000
-40.0%
6,0000.0%0.00%
-100.0%
Q3 2021$10,000
-33.3%
6,0000.0%0.00%0.0%
Q2 2021$15,000
-28.6%
6,0000.0%0.00%0.0%
Q1 2021$21,000
+40.0%
6,0000.0%0.00%0.0%
Q4 2020$15,0000.0%6,0000.0%0.00%0.0%
Q3 2020$15,000
-21.1%
6,0000.0%0.00%
-50.0%
Q2 2020$19,000
+35.7%
6,0000.0%0.00%
+100.0%
Q1 2020$14,000
-50.0%
6,0000.0%0.00%
-50.0%
Q4 2019$28,000
+12.0%
6,0000.0%0.00%0.0%
Q3 2019$25,000
-26.5%
6,0000.0%0.00%
-33.3%
Q2 2019$34,000
+47.8%
6,0000.0%0.00%
+50.0%
Q1 2019$23,000
+76.9%
6,0000.0%0.00%
+100.0%
Q4 2018$13,000
-31.6%
6,0000.0%0.00%
-50.0%
Q3 2018$19,000
+5.6%
6,0000.0%0.00%0.0%
Q2 2018$18,000
-21.7%
6,0000.0%0.00%
-33.3%
Q1 2018$23,000
-4.2%
6,0000.0%0.00%0.0%
Q4 2017$24,000
-38.5%
6,0000.0%0.00%
-25.0%
Q3 2017$39,000
+5.4%
6,0000.0%0.00%0.0%
Q2 2017$37,000
-2.6%
6,0000.0%0.00%
-20.0%
Q1 2017$38,000
+18.8%
6,0000.0%0.01%0.0%
Q4 2016$32,000
-3.0%
6,0000.0%0.01%0.0%
Q3 2016$33,000
+3.1%
6,0000.0%0.01%0.0%
Q2 2016$32,000
-27.3%
6,0000.0%0.01%
-37.5%
Q1 2016$44,000
+69.2%
6,000
+100.0%
0.01%
-52.9%
Q4 2014$26,0003,0000.02%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders